The Food and Drug Administration and IBM Watson Health are forming a partnership to investigate potential ways that blockchain technology can be used in healthcare.

The agency and IBM subsidiary have signed a two-year agreement that will enable them to jointly explore ways to use the emerging technology. Initial efforts will focus on oncology-related data.

Register or login for access to this item and much more

All Digital Insurance content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access